Genetic counselling helps people understand genetic or inherited disorders. It can help families learn about neurofibromatosis type 1 (NF1) and decide if testing is right for them.
Neurofibromatosis type 1 (NF1) is a skin condition that causes growths on nerves. Find out what NF1 genetic testing is, what the test results mean and why to consider testing for it.
Learn about clinical and genetic testing, two ways that doctors diagnose Neurofibromatosis Type 1 (NF1). Each of these methods has advantages and limits.
Neurofibromatosis Type 1 (NF1) occurs because of a mutation to the NF1 gene. About half of cases are spontaneous mutations, while the other half are inherited from a parent to a child.
Learn how the complications of Neurofibromatosis Type 1 (NF1) are treated.
A child with neurofibromatosis type 1 must have consistent medical care. Parents can use this checklist to ensure their child receives all the care they need.
A list of websites with in-depth information on neurofibromatosis type 1 (NF1) in children.
Neurofibromatosis or NF1 causes growths to form on nerve tissues. Learn about both the common and uncommon skin and bone abnormalities of this condition.
Genetics can play an important role in your family's health. Learn more about genetics; genetic counselling, screening, and diagnosis; different genetic conditions; and how genetics relate to understanding and managing overall health.
Genetic counselling is a process that provides information and support to individuals and families at risk of, or with, a genetic condition.
Acute lymphoblastic leukemia (ALL) is the most common childhood cancer. Learn about how this cancer develops and what factors may affect the development of the disease.
Read about the many different types of low-grade gliomas, including cerebellar, optic, brainstem, hemispheric, thalamic, and spinal cord.
Learn about TPMT, a gene tested through pharmacogenetic testing to predict an individual’s response to certain medications.
Learn about NUDT15, a gene tested through pharmacogenetic testing to predict an individual’s response to certain medications.
Learn about genetics in the context of pharmacogenetics (PGx) and precision medicine.
Albinism is a genetic condition that causes a person to have no, or very little, pigment in the eyes and sometimes in the skin and hair also. Albinism is passed from parent to child because of a genetic mutation.
Understanding your child's cleft lip and/or palate through genetic assessments.
Skeletal dysplasia is a term used to describe a group of genetic conditions that cause abnormal formation of bone and cartilage. Growth and other bodily functions may also be affected.
Learn about CYP2D6, a gene tested through pharmacogenetic testing to predict an individual’s response to certain medications.
Learn about pharmacogenetics (PGx) testing is performed, which genes are currently tested and how the results of PGx testing can help inform your child's health-care team.
Learn about VKORC1, a gene tested through pharmacogenetic testing to predict an individual’s response to certain medications.
Tuberous sclerosis complex (TSC) is a genetic condition. Learn what causes it, and how it is diagnosed and treated.
Learn the answers to frequently asked questions about pharmacogenetics.
Learn about CYP2C19, a gene tested through pharmacogenetic testing to predict an individual’s response to certain medications.
